The University of Chicago Header Logo

Connection

Ezra Cohen to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Ezra Cohen has written about Cost-Benefit Analysis.
Ezra Cohen
Connection Strength
0.120
Cost-Benefit Analysis
  1. Current treatment options for metastatic head and neck cancer. Curr Treat Options Oncol. 2012 Mar; 13(1):35-46.
    View in: PubMed
    Score: 0.084
  2. Cost-effectiveness analysis of nivolumab for the treatment of squamous cell carcinoma of the head and neck in the United States. J Med Econ. 2020 May; 23(5):442-447.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.